Status:
UNKNOWN
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Klebsiella Pneumoniae Sepsis
Eligibility:
All Genders
21-100 years
Brief Summary
Nosocomial infections are increasing rapidly both internationally and domestically, especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still lack of evidence about t...
Eligibility Criteria
Inclusion
- All adult patients (≥18 years) with K. pneumoniae bloodstream infection were included. Patients were excluded if there was other recognized bacteremia within two weeks before or after the first episode of K. pneumoniae bloodstream infection.
Exclusion
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04337840
Start Date
May 5 2020
End Date
March 1 2022
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan